— Know what they know.
Not Investment Advice

RGC NASDAQ

Regencell Bioscience Holdings Limited
1W: +10.5% 1M: +8.1% 3M: +21.6% YTD: -66.8% 1Y: -56.9% 3Y: +1497.8% 5Y: +749.7%
$6.82
+0.49 (+7.74%)
 
Weekly Expected Move ±10.5%
$5 $6 $7 $8 $8
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 60 · $3.4B mcap · 17M float · 1.49% daily turnover · Short 42% of daily vol

Balance Sheet Trends

Total Assets
$6M -31.8% ▼
5Y CAGR: +62.1%
Total Liabilities
$895K +307.9% ▲
5Y CAGR: -22.3%
Shareholders Equity
$5M -40.9% ▼
Cash & Investments
$5M -38.5% ▼
5Y CAGR: +66.1%
Total Debt
$544K +535.0% ▲
5Y CAGR: -29.2%
Net Debt
-$2M +34.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$59K$6M$2M$3M$2M
Short-Term Investments$0$10M$10M$5M$2M
Cash & ST Investments$59K$16M$12M$8M$5M
Net Receivables$7K$28K$57K$153K$0
Inventory$0-$28K-$57K$0$0
Other Current Assets-$7K$0$0$0$6K
Total Current Assets$67K$16M$12M$8M$5M
Property, Plant & Equip.$82K$1M$892K$227K$760K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$191K$114K$108K$98K$93K
Total Non-Current Assets$273K$2M$1M$324K$853K
Total Assets$340K$18M$13M$8M$6M
— Liabilities —
Accounts Payable$0$0$0$0$0
Short-Term Debt$4M$411K$0$0$313K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0-$411K$0$0$351K
Total Current Liabilities$4M$578K$607K$194K$664K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$360K$25K$26K$232K
Total Liabilities$4M$938K$632K$220K$895K
— Equity —
Common Stock$100$130$130$130$5K
Retained Earnings-$4M-$11M-$17M-$22M-$25M
Accumulated OCI$0$0-$87K-$46K-$65K
Total Stockholders Equity-$4M$17M$12M$8M$5M
Total Liabilities & Equity$340K$18M$13M$8M$6M
— Key Metrics —
Total Debt$4M$771K$464K$86K$544K
Net Debt$4M-$6M-$1M-$3M-$2M
Total Investments$0$10M$10M$5M$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms